30 – 31 October 2019

Aesch, Switzerland

USP Course (II)

Course CM-1092-02
"Dissolution - Method Development with Case Studies"
 

Course Overview

Building on your basic understanding of USP’s approach to dissolution, this course provides a foundation for developing and validating dissolution, disintegration and drug release methods used in product development, batch release and stability testing. These tests are in vitro performance tests for dosage forms, such as tablets, capsules, suspensions, transdermal patches and suppositories. They are important components of the
specifications that establish the strength, quality, purity and bioavailability of a drug product. On the second day, real case studies will be discussed in an interactive group activity.


Learning Objectives

By taking this course, you will learn about:
• Development of dissolution and drug release testing methods based on physicochemical characterization of drug substances
• Physiological considerations when setting up tests
• Selection of dissolution testing conditions, such as instruments and media
• Interpretation of dissolution test results
• Validation


Registration

To register or for information on group pricing, please visit http://education.usp.org or email education@usp.org.

Visit Us

  • USP Course (II)
  • 30 – 31 October 2019
  • Aesch, Switzerland
  • SOTAX AG, Aesch